VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts21212022
Avg. Estimate1.011.083.774.68
Low Estimate0.880.893.463.25
High Estimate1.171.274.116.02
Year Ago EPS0.530.611.953.77
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts19192022
Avg. Estimate787.01M825.97M3B3.53B
Low Estimate743.8M793.14M2.95B3.04B
High Estimate829.17M876.66M3.09B3.87B
Year Ago Sales551.87M622.63M2.17B3B
Sales Growth (year/est)42.60%32.70%38.20%17.60%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.0.310.530.630.75
EPS Actual0.530.610.760.94
Difference0.220.080.130.19
Surprise %71.00%15.10%20.60%25.30%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate1.011.083.774.68
7 Days Ago1.011.083.774.68
30 Days Ago0.820.93.24.57
60 Days Ago0.820.93.194.56
90 Days Ago0.820.93.24.56
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/A1
Up Last 30 Days19172113
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days111N/A
Growth EstimatesVRTXIndustrySectorS&P 500
Current Qtr.90.60%N/AN/A0.47
Next Qtr.77.00%N/AN/A0.46
Current Year93.30%N/AN/A0.22
Next Year24.10%N/AN/A0.10
Next 5 Years (per annum)57.70%N/AN/A0.11
Past 5 Years (per annum)55.90%N/AN/AN/A